Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) said it has completed a new artificial intelligence (AI) model to deliver the first clinically meaningful analysis of its unique human challenge trial data in the first half of next year, with the aim of identifying novel influenza drug targets.

Read more here.